Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening Academic Article uri icon

Overview

MeSH Major

  • African Americans
  • Early Detection of Cancer
  • Prostatic Neoplasms

abstract

  • Basing decisions for early screening on prostate specific antigen at age 45 years provided the best ratio between men screened and potential cancer deaths avoided. Given the lack of evidence that race or family history affects the relationship between prostate specific antigen and risk, prostate specific antigen based risk stratification would likely include any black men or men with a family history who are destined to experience aggressive disease. Differential screening based on risk should be informed by baseline prostate specific antigen.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4143426

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2014.03.032

PubMed ID

  • 24641912

Additional Document Info

start page

  • 724

end page

  • 8

volume

  • 192

number

  • 3